# FDA Inspection 1120564 - Somerville Acquisitions, Inc. - January 30, 2020

Source: https://www.keypedia.com/records/fda_inspections/somerville-acquisitions-inc/bec622f2-7f80-453a-a0e7-3ffa92f831d9
Source feed: FDA_Inspections

> FDA Inspection 1120564 for Somerville Acquisitions, Inc. on January 30, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120564
- Company Name: Somerville Acquisitions, Inc.
- Inspection Date: 2020-01-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1272925 - 2025-06-04](https://www.keypedia.com/records/fda_inspections/somerville-acquisitions-inc/c35ab5e9-f2f1-4af1-aa02-290fa8dcfddc)
- [FDA Inspection 1272925 - 2025-06-04](https://www.keypedia.com/records/fda_inspections/somerville-acquisitions-inc/6d59ffba-6171-4bcd-a5b0-fdc67acbed23)
- [FDA Inspection 857121 - 2013-12-03](https://www.keypedia.com/records/fda_inspections/somerville-acquisitions-inc/7279acf7-3f2c-4eed-ad4d-f87e1934e500)
- [FDA Inspection 739753 - 2011-08-15](https://www.keypedia.com/records/fda_inspections/somerville-acquisitions-inc/075edcab-4d32-4051-9f7e-e638200b57d8)
- [FDA Inspection 646902 - 2010-02-16](https://www.keypedia.com/records/fda_inspections/somerville-acquisitions-inc/6f20abc4-b248-496d-baec-2344e6ec4a33)

Company: https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c